| 8.1 Overall fatigue change |
14 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.1.1 Up to 12 weeks' follow‐up |
10 |
745 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.82 [‐1.50, ‐0.14] |
| 8.1.2 More than 12 weeks' less than 6 months' follow‐up |
3 |
246 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.42 [‐0.83, ‐0.02] |
| 8.1.3 6 months' follow‐up |
3 |
514 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.06 [‐0.31, 0.19] |
| 8.1.4 More than 6 months' follow‐up |
1 |
82 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.38 [‐0.82, 0.06] |
| 8.2 Overall fatigue follow‐up values |
22 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.2.1 Up to 12 weeks' follow‐up |
18 |
994 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.30 [‐0.46, ‐0.14] |
| 8.2.2 More than 12 weeks' less than 6 months' follow‐up |
5 |
436 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.03 [‐0.31, 0.25] |
| 8.2.3 6 months' follow‐up |
2 |
110 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.10 [‐0.48, 0.27] |
| 8.3 FACT fatigue subscale change |
6 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.3.1 Up to 12 weeks' follow‐up |
4 |
296 |
Mean Difference (IV, Random, 95% CI) |
4.33 [2.43, 6.22] |
| 8.3.2 More than 12 weeks' less than 6 months' follow‐up |
2 |
145 |
Mean Difference (IV, Random, 95% CI) |
‐3.97 [‐10.53, 2.60] |
| 8.3.3 6 months' follow‐up |
1 |
36 |
Mean Difference (IV, Random, 95% CI) |
1.28 [‐4.11, 6.67] |
| 8.4 FACT fatigue subscale follow‐up values |
11 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.4.1 Up to 12 weeks' follow‐up |
9 |
550 |
Mean Difference (IV, Random, 95% CI) |
2.00 [0.00, 3.99] |
| 8.4.2 More than 12 weeks' up to 6 months' follow‐up |
3 |
250 |
Mean Difference (IV, Random, 95% CI) |
0.21 [‐2.04, 2.45] |
| 8.4.3 6 months' follow‐up |
1 |
36 |
Mean Difference (IV, Random, 95% CI) |
0.30 [‐7.22, 7.82] |
| 8.5 QLQ‐C30 fatigue subscale change |
4 |
259 |
Mean Difference (IV, Random, 95% CI) |
‐15.38 [‐39.15, 8.38] |
| 8.5.1 Up to 12 weeks' follow‐up |
3 |
158 |
Mean Difference (IV, Random, 95% CI) |
‐22.45 [‐50.66, 5.77] |
| 8.5.2 More than 12 weeks' less than 6 months' follow‐up |
1 |
101 |
Mean Difference (IV, Random, 95% CI) |
11.20 [2.36, 20.04] |
| 8.6 QLQ‐C30 fatigue subscale follow‐up values |
5 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.6.1 Up to 12 weeks' follow‐up |
4 |
256 |
Mean Difference (IV, Random, 95% CI) |
‐7.50 [‐12.92, ‐2.07] |
| 8.6.2 More than 12 weeks' less than 6 months' follow‐up |
2 |
206 |
Mean Difference (IV, Random, 95% CI) |
3.03 [‐6.67, 12.73] |
| 8.7 Multidimensional Fatigue Inventory follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.7.1 Up to 12 weeks' follow‐up |
1 |
87 |
Mean Difference (IV, Random, 95% CI) |
‐0.21 [‐0.58, 0.16] |
| 8.8 MOS SF‐36 vitality subscale change |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.8.1 Up to 12 weeks' follow‐up |
1 |
58 |
Mean Difference (IV, Random, 95% CI) |
2.90 [‐6.33, 12.13] |
| 8.8.2 6 months' follow‐up |
1 |
74 |
Mean Difference (IV, Random, 95% CI) |
0.40 [‐2.72, 3.52] |
| 8.9 MOS SF‐36 vitality subscale follow‐up values |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.9.1 Up to 12 weeks' follow‐up |
1 |
58 |
Mean Difference (IV, Random, 95% CI) |
8.09 [‐1.39, 17.57] |
| 8.9.2 6 months' follow‐up |
1 |
74 |
Mean Difference (IV, Random, 95% CI) |
1.30 [‐3.03, 5.63] |
| 8.10 Piper Revised Fatigue Scale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.10.1 Up to 12 weeks' follow‐up |
1 |
66 |
Mean Difference (IV, Random, 95% CI) |
‐1.30 [‐2.17, ‐0.43] |
| 8.10.2 More than 12 weeks' less than 6 months' follow‐up |
1 |
59 |
Mean Difference (IV, Random, 95% CI) |
‐0.78 [‐1.83, 0.27] |
| 8.11 Schwartz Cancer Fatigue scale change |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.11.1 Up to 12 weeks' follow‐up |
1 |
58 |
Mean Difference (IV, Random, 95% CI) |
‐2.20 [‐4.32, ‐0.08] |
| 8.12 Linear Analog Self‐Assessment energy scale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.12.1 Up to 12 weeks' follow‐up |
1 |
21 |
Mean Difference (IV, Random, 95% CI) |
‐19.00 [‐31.89, ‐6.11] |
| 8.13 Linear Analog Self‐Assessment scale change |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.13.1 Up to 12 weeks' follow‐up |
1 |
82 |
Mean Difference (IV, Random, 95% CI) |
‐13.14 [‐23.32, ‐2.96] |
| 8.13.2 6 months' follow‐up |
1 |
404 |
Mean Difference (IV, Random, 95% CI) |
‐2.44 [‐13.06, 8.18] |
| 8.13.3 More than 6 months' follow‐up |
1 |
82 |
Mean Difference (IV, Random, 95% CI) |
‐9.47 [‐20.13, 1.19] |
| 8.14 Linear Analog Self‐Assessment scale follow‐up values |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.14.1 Up to 12 weeks' follow‐up |
2 |
103 |
Mean Difference (IV, Random, 95% CI) |
‐15.40 [‐25.08, ‐5.73] |
| 8.15 Schwartz Cancer Fatigue scale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.15.1 Up to 12 weeks' follow‐up |
1 |
58 |
Mean Difference (IV, Random, 95% CI) |
‐4.00 [‐6.03, ‐1.97] |
| 8.16 POMS fatigue subscale change |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.16.1 Up to 12 weeks' follow‐up |
2 |
275 |
Mean Difference (IV, Random, 95% CI) |
‐0.17 [‐2.25, 1.92] |
| 8.17 POMS ‐ fatigue subscale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.17.1 Up to 12 weeks' follow‐up |
1 |
24 |
Mean Difference (IV, Random, 95% CI) |
‐1.84 [‐6.96, 3.28] |
| 8.18 POMS vigor subscale change |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.18.1 Up to 12 weeks' follow‐up |
2 |
275 |
Mean Difference (IV, Random, 95% CI) |
2.37 [‐1.70, 6.44] |
| 8.18.2 6 months' follow‐up |
1 |
82 |
Mean Difference (IV, Random, 95% CI) |
2.23 [‐0.48, 4.94] |
| 8.18.3 More than 6 months' follow‐up |
1 |
82 |
Mean Difference (IV, Random, 95% CI) |
0.84 [‐1.89, 3.57] |
| 8.19 POMS vigor subscale follow‐up values |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 8.19.1 Up to 12 weeks' follow‐up |
1 |
82 |
Mean Difference (IV, Fixed, 95% CI) |
4.77 [2.36, 7.18] |
| 8.20 POMS short form vigor follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.20.1 Up to 12 weeks' follow‐up |
1 |
86 |
Mean Difference (IV, Random, 95% CI) |
0.27 [‐0.07, 0.61] |
| 8.20.2 More than 12 weeks' less than 6 months' follow‐up |
1 |
85 |
Mean Difference (IV, Random, 95% CI) |
0.39 [0.05, 0.73] |
| 8.21 Brief Fatigue Inventory follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 8.21.1 Up to 12 weeks' follow‐up |
1 |
30 |
Mean Difference (IV, Random, 95% CI) |
0.00 [‐1.08, 1.08] |
